13F-HR filed by Eagle Health Investments LP
Eagle Health Investments LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-12, with 25 holding rows worth $528,001,084.
- Accession
- 0001172661-24-004568
- Filer
- CIK 1842545
- Filed
- 2024-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 25 entries on the cover page, a total value of $528,001,084 stated on the cover page (in dollars after the unit check, H1), rows summing to $528,001,084 with VALUE read as dollars as filed, 13F file number 028-20556. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NATERA INC COM | 632307104 | Stock | 431,314 | $54,755,312 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 387,354 | $50,514,835 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 74,990 | $40,650,579 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 130,790 | $37,577,275 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 513,700 | $37,500,100 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 544,200 | $37,070,904 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 561,700 | $31,202,435 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 451,492 | $30,268,024 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 50,700 | $29,643,276 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 419,212 | $29,466,411 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 136,603 | $28,830,063 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 76,256 | $20,972,688 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 54,099 | $19,386,377 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 233,089 | $18,675,091 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 128,600 | $14,817,292 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 330,830 | $14,698,777 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 197,000 | $9,255,060 | dollars as filed | put |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 462,911 | $5,004,068 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 43,200 | $4,741,200 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 7,390 | $3,630,485 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 45,000 | $2,848,950 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 18,061 | $2,835,577 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 700,000 | $1,484,000 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 46,300 | $1,441,319 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 53,124 | $730,986 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-004568 | this filing | 2024-11-12 | acceptance time not in the bulk data set |